Global $11 Billion Non-Hodgkin Lymphoma Market Outlook, 2024-2029: Focus on T-cell Lymphoma and Immunotherapies [Yahoo! Finance]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ResearchAndMarkets.com's offering. The global Non-Hodgkin Lymphoma market has experienced significant growth, with estimates indicating a surge from USD 7.14 billion in 2023 to USD 11 billion by 2029, showcasing a robust CAGR of 7.55%. This report offers an in-depth analysis of this dynamic market, highlighting key drivers such as regulatory approvals, innovative therapies, and clinical trials geared towards drugs for Non-Hodgkin Lymphoma (NHL). The NHL market's expansion is greatly influenced by advancements in treatment options and the increasing number of clinical trials. Novel immunotherapies and targeted therapies, stemming from rigorous research initiatives, have demonstrated enhanced efficacy and have been pivotal in transforming the treatment paradigm for NHL. Regulatory approvals from authorities like the U.S. Food and Drug Administration and other international entities have bolstered th
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal [Yahoo! Finance]Yahoo! Finance
- In NCLA Amicus Win, and FTC Amicus Loss, Second Circuit Upholds Decision Dismissing Antitrust Suit [Yahoo! Finance]Yahoo! Finance
- Euronext Paris Growth Leaders With High Insider Stakes May 2024 [Yahoo! Finance]Yahoo! Finance
- Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks [Yahoo! Finance]Yahoo! Finance
- AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders [Yahoo! Finance]Yahoo! Finance
ABBV
Earnings
- 4/26/24 - Miss
ABBV
Sec Filings
- 5/8/24 - Form 8-K/A
- 5/7/24 - Form 4
- 5/7/24 - Form 4
- ABBV's page on the SEC website